BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18692928)

  • 1. Abdominal cancer during early childhood: a dosimetric comparison of proton beams to standard and advanced photon radiotherapy.
    Hillbrand M; Georg D; Gadner H; Pötter R; Dieckmann K
    Radiother Oncol; 2008 Nov; 89(2):141-9. PubMed ID: 18692928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
    Weber DC; Trofimov AV; Delaney TF; Bortfeld T
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
    Baumert BG; Norton IA; Lomax AJ; Davis JB
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can protons improve SBRT for lung lesions? Dosimetric considerations.
    Georg D; Hillbrand M; Stock M; Dieckmann K; Pötter R
    Radiother Oncol; 2008 Sep; 88(3):368-75. PubMed ID: 18405986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study.
    Mu X; Björk-Eriksson T; Nill S; Oelfke U; Johansson KA; Gagliardi G; Johansson L; Karlsson M; Zackrisson DB
    Acta Oncol; 2005; 44(6):554-62. PubMed ID: 16165914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.
    Wang X; Krishnan S; Zhang X; Dong L; Briere T; Crane CH; Martel M; Gillin M; Mohan R; Beddar S
    Med Dosim; 2008; 33(4):259-67. PubMed ID: 18973852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose painting with IMPT, helical tomotherapy and IMXT: a dosimetric comparison.
    Thorwarth D; Soukup M; Alber M
    Radiother Oncol; 2008 Jan; 86(1):30-4. PubMed ID: 18061294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton versus photon radiation therapy for patients with high-risk neuroblastoma: the need for a customized approach.
    Hill-Kayser C; Tochner Z; Both S; Lustig R; Reilly A; Balamuth N; Womer R; Maris J; Grupp S; Bagatell R
    Pediatr Blood Cancer; 2013 Oct; 60(10):1606-11. PubMed ID: 23737005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.
    Brodin NP; Munck Af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Vogelius IR; Nilsson P; Lannering B; Björk-Eriksson T
    Acta Oncol; 2011 Aug; 50(6):806-16. PubMed ID: 21767178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformal proton radiation treatment for retroperitoneal neuroblastoma: introduction of a novel technique.
    Hug EB; Nevinny-Stickel M; Fuss M; Miller DW; Schaefer RA; Slater JD
    Med Pediatr Oncol; 2001 Jul; 37(1):36-41. PubMed ID: 11466721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.
    Feuvret L; Noel G; Weber DC; Pommier P; Ferrand R; De Marzi L; Dhermain F; Alapetite C; Mammar H; Boisserie G; Habrand JL; Mazeron JJ
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):944-54. PubMed ID: 17889276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons.
    MacDonald SM; Safai S; Trofimov A; Wolfgang J; Fullerton B; Yeap BY; Bortfeld T; Tarbell NJ; Yock T
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):979-86. PubMed ID: 18325681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
    Kozak KR; Adams J; Krejcarek SJ; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):179-86. PubMed ID: 19019562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.
    Yock T; Schneider R; Friedmann A; Adams J; Fullerton B; Tarbell N
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1161-8. PubMed ID: 15950401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy.
    Yoon M; Shin DH; Kim J; Kim JW; Kim DW; Park SY; Lee SB; Kim JY; Park HJ; Park BK; Shin SH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):637-46. PubMed ID: 20932690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity modulated photon and proton therapy for the treatment of head and neck tumors.
    Steneker M; Lomax A; Schneider U
    Radiother Oncol; 2006 Aug; 80(2):263-7. PubMed ID: 16916557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.